Implementation of CardioVascular Disease Risk Assessment by Pharmacy in secondary care for high-risk ethnicities

Christchurch Hospital Pharmacy Department0 个研究点目标入组 200 人开始时间: 2024年7月30日最近更新: 2024年8月12日

适应症

试验速览

暂无简介。

•oMaori or Pacific Male* aged 30 or above
•oMaori or Pacific Female* aged 40 or above
•oLive in greater Christchurch area to ensure appropriate community follow up can be arranged.
•(*Sex at birth)

•High risk CVD features that automatically define risk as > 15%
•oHeart failure
•oCoronary or carotid artery disease from imaging (unlikely to have in community)
•oeGFR < 30 mL/min or < 45mL/min with diabetes
•oPrevious Cardiovascular event
•oFamilial hypercholesterolaemia
•oAge greater than 75 (as the PREDICT CVD RA tool is only validated for < 75 years)
•oPregnant / Breastfeeding
•oNot appropriate due to clinical or emotional status (too unwell) or prognosis (short life expectancy)
•Note: If deemed inappropriate due to current clinical status, this can be reassessed at a later date during their admission
•oPatient had CVD RA completed previously + clearly recalls their risk level AND is not due to repeat assessment (see below) AND appears appropriately treated for risk level.
•Note: Due to variance in completion rates / quality / timeliness and patient recall of previous CVD RA – better to assess again if any concerns to appropriately manage cardio-vascular disease risk.
•Recommended interval for repeat CVD risk assessment
•Risk < 3% – ten years
•Risk 3–9% – five years
•Risk 10–14% – two years
•Risk = 15% – one year
•Risk 5–15% and prescribed pharmacological interventions – one year
•Severe mental illness – two years (or one year if risk greater than or equal to 15%)

发起方

Christchurch Hospital Pharmacy Department